CRP and rheumatoid arthritis: Treatment with salazosulfapyridine and prednisolone (PSL) at 5 mg/day was ineffective and the RA activity remained very high (DAS28-CRP: 6.3, Clinical Disease Activity Index (CDAI): 34.5, and CRP: 6.6 mg/dL).